Accommodation Agreement. The Accommodation Agreement must be signed before check-in, at the beginning of May for the second, third and fourth-year-students and within the last two weeks of August for the first year students (Greek first-year students sign the Αgreement at the beginning of September). The Αgreement covers the period which begins the first Monday of the Fall Semester and expires on the 31st of May every academic year. In case a student who has been chosen does not sign the Αgreement within the determined deadline, and he has not informed the housing office about problems that probably occurred, then it will be assumed that he is not interested any more, thus the room will be rented to another candidate without any warning. The University of Cyprus authorizes the Housing Office to extend or to cease before time the Accommodation Agreement when: 2.1. The tenant has the right to extend his accommodation to his room after the expiration date of the Αgreement during summer time, if he informs the Housing Office at least one month before the expiration date of the Agreement, and having his Departmental affirmation that during summer holidays he is obliged to attend some courses and/or lab exercises. 2.2. The University of Cyprus has the right to cancel or to cease before time the Accommodation Agreement if: 2.2.1. The tenant has not registered to semester courses according to the affirmation of the Academic Affairs Office, which is sent to the Housing Office at the end of September after the registrations and add/drop procedure. 2.2.2. The tenant leaves or if he is expunged by the University of Cyprus according to the Academic Affairs Office affirmation. 2.2.3. If the tenant is not punctual with his financial obligations (deposit / rent/ penalty). 2.2.4. If the tenant does not follow the Agreement’s rules and the Accommodation Rules (see paragraph 18). 2.2.5. If the tenant does not present within the determined deadline for room check-in according to paragraph 3.

Accommodation Agreement. As a condition precedent to the effectiveness of this Agreement, the Accommodation Agreement shall have been executed by all of the parties thereto and become fully effective. Each of the Restructuring Lenders (i) acknowledges the terms of, consents to and agrees to be bound in all respects by the Accommodation Agreement, and (ii) agrees that in the event there is any conflict between the terms and conditions of any of the Restructuring Lender Documents and the Accommodation Agreement, the terms and conditions of the Accommodation Agreement shall prevail. Each Restructuring Lender agrees that the Accommodation Agreement shall be binding on it and its successors and assigns. In the event that any Restructuring Lender desires to assign all or any portion of its Restructuring Lender Obligations to any Person, as a condition precedent to the effectiveness of such assignment, such Restructuring Lender shall cause such Person to agree in writing to be bound by and to become a party to the Accommodation Agreement.

Accommodation Agreement. As a condition precedent to the effectiveness of this Agreement, the Accommodation Agreement shall have been executed by all of the parties thereto and become fully effective. Each of the LIFO Lenders (i) acknowledges the terms of, consents to and agrees to be bound in all respects by the Accommodation Agreement, and (ii) agrees that in the event there is any conflict between the terms and conditions of any of the LIFO Lender Documents and the Accommodation Agreement, the terms and conditions of the Accommodation Agreement shall prevail. Each LIFO Lender agrees that the Accommodation Agreement shall be binding on it and its successors and assigns. In the event that any LIFO Lender desires to assign all or any portion of its LIFO Lender Obligations to any Person, as a condition precedent to the effectiveness of such assignment, such LIFO Lender shall cause such Person to agree in writing to be bound by and to become a party to the Accommodation Agreement.

Accommodation Agreement. 1.1 Accommodation of guests at the Royal Regent Hotel takes place on the basis of an accommodation agreement concluded in accordance with the provisions of Section 2326 et seq. of Act. No. 89/2012 Coll., the Civil Code, on the basis of which the Royal Regent Hotel (hereinafter referred to as the ‘Accommodation Provider’) provides the accommodated person with temporary accommodation for an agreed period of time or for a period resulting from the purpose of accommodation in the facility designated for that purpose by the Accommodation Provider and the accommodated person (hereinafter also referred to as the ‘Guest’) undertakes to pay the Accommodation Provider for the accommodation and the services connected with it within the period set by this Accommodation Agreement. 1.2 The Accommodation Agreement is always entered into in writing. To comply with all requisites, a confirmation of the order or reservation in writing is sufficient. 1.3 The rights and obligations of the contracting parties not expressly regulated by the Accommodation Agreement are governed by these Accommodation Rules, the Accommodation Provider’s general terms and conditions and the price list of the Accommodation Provider’s services. If the Accommodation Agreement stipulates something other than stipulated in these Accommodation Rules and/or the Accommodation Provider’s price list, the Accommodation Agreement shall apply. 1.4 If the Guest fails to comply with the obligations arising for them under the Accommodation Agreement and the attached Accommodation Rules and/or the Accommodation Provider’s price list or violates the good morals of the hotel in some other manner (hereinafter ‘misconduct’), the Accommodation Provider is entitled to terminate the Accommodation Agreement before lapse of the agreed period, and may do so without notice, if the Guest was notified of their misconduct by the hotel pursuant to Section 2331 of the Civil Code.

Accommodation Agreement. The Parties acknowledge and agree that: (a) The outside date of the Accommodation Period (as defined in the Accommodation Agreement) shall be extended to the earliest of (i) the Closing Date, and (ii) the date upon which this Agreement is terminated in accordance with Section 6.9; and (b) Subject to foregoing Section 6.6(a), all terms, conditions, rights and remedies as set out in the Accommodation Agreement shall continue in full force and effect.

Accommodation Agreement. ❑ I/we accept the terms and conditions of the Welfare and Accommodation Agreement (Section B.2) ❑ I/we accept the terms and conditions of the Code of Conduct and Bullying Policy Agreement (Section B.3 and B.4)

Related to Accommodation Agreement

Transition Agreement In the event of termination of this Agreement in its entirety by AbbVie pursuant to Section 12.3.2 or by Galapagos pursuant to Section 12.2.1, or with respect to one (1) or more countries or other jurisdictions by AbbVie pursuant to Section 12.3 or by Galapagos pursuant to Section 12.2.2(i), Galapagos and AbbVie shall negotiate in good faith the terms and conditions of a written transition agreement (the “Transition Agreement”) pursuant to which AbbVie and Galapagos will effectuate and coordinate a smooth and efficient transition of relevant obligations and rights to Galapagos as reasonably necessary for Galapagos to exercise the licenses granted pursuant to Sections 12.6 or 12.7 after termination of this Agreement (in its entirety or with respect to one (1) or more countries or other jurisdictions, as applicable) as and to the extent set forth in this Article 12. For clarity, AbbVie shall not be required to Manufacture or have Manufactured the Molecules or Products by or on behalf of Galapagos as part of the Transition Agreement. 12.8.1 The Transition Agreement shall provide that in the event of a termination of this Agreement in its entirety by AbbVie pursuant to Section 12.3.2 or by Galapagos in its entirety pursuant to Section 12.2.1, AbbVie shall: (i) where permitted by Applicable Law, transfer to Galapagos all of its right, title, and interest in all Regulatory Documentation then Controlled by AbbVie or its Affiliates or Sublicensees and in its/their name applicable to the Products in the Territory that are the subject of an exclusive license grant in Section 12.6.1(iii); (ii) notify the applicable Regulatory Authorities and take any other action reasonably necessary to effect the transfer set forth in clause (i) above; (iii) if requested by Galapagos and unless expressly prohibited by any Regulatory Authority, transfer control to Galapagos of all Clinical Studies being Conducted by AbbVie or its Affiliates or Sublicensees as of the effective date of termination and continue to Conduct such Clinical Studies, at Galapagos’ cost, for up to […***…] ([…***…]) months to enable such transfer to be completed without interruption of any such Clinical Study; provided, that (a) Galapagos shall not have any obligation to continue any Clinical Study unless required by Applicable Law, and (b) with respect to each Clinical Study for which such transfer is expressly prohibited by the applicable Regulatory Authority, if any, AbbVie shall continue to Conduct such Clinical Study to completion, at Galapagos’ cost; and (iv) assign (or cause its Affiliates or Sublicensees to assign) to Galapagos all agreements with any Third Party with respect to the Conduct of pre-clinical Development activities, Clinical Studies or Manufacturing activities for the Products, including agreements with contract research organizations, clinical sites, and investigators, unless, with respect to any such agreement, (a) Galapagos declines such assignment, or (b) such agreement (1) expressly prohibits such assignment, in which case AbbVie shall cooperate with Galapagos in reasonable respects to secure the consent of the applicable Third Party to such assignment, or (2) covers products covered by Patents Controlled by AbbVie or any of its Affiliates in addition to the Products, in which case AbbVie shall, at Galapagos’ sole cost and expense, cooperate with Galapagos in all reasonable respects to facilitate the execution of a new agreement between Galapagos and the applicable Third Party. 12.8.2 The Transition Agreement shall provide that in the event of a termination of this Agreement with respect to a country or other jurisdiction by AbbVie pursuant to Section 12.3 or by Galapagos pursuant to Section 12.2.2(i) (but not in the case of any termination of this Agreement in its entirety), AbbVie shall: (i) where permitted by Applicable Law, transfer to Galapagos all of its right, title, and interest in all Regulatory Approvals owned by, or in the name of, AbbVie or its Affiliates or Sublicensees, which Regulatory Approvals are solely applicable to the relevant country or jurisdiction and the Products that are the subject of an exclusive license grant in Section 12.7, as such Regulatory Approvals exists as of the effective date of such termination of this Agreement with respect to such relevant country or jurisdiction; provided, that AbbVie retains a license and right of reference under any Regulatory Approval transferred pursuant to this clause as necessary or reasonably useful for AbbVie to Commercialize Products in the Territory, Develop Molecules or Products in support of such Commercialization, or Manufacture Molecules or Products in support of such Development or Commercialization; (ii) notify the applicable Regulatory Authorities and take any other action reasonably necessary to effect the transfer set forth in clause (i) above; (iii) grant Galapagos a right of reference to all Regulatory Documentation then owned by, or in the name of, AbbVie or its Affiliates or Sublicensees, and which Regulatory Documentation is not transferred to Galapagos pursuant to clause (i) above, and is necessary or reasonably useful for Galapagos, any of its Affiliates or sublicensees to Develop or Commercialize in the terminated country or jurisdiction the Product(s) that are the subject of the license grant in Section 12.7 as such Regulatory Documentation exists as of the effective date of such termination of this Agreement with respect to such terminated country or jurisdiction; (iv) if requested by Galapagos and unless expressly prohibited by any Regulatory Authority, transfer control to Galapagos of all Clinical Studies specific to such terminated country(ies) being Conducted by AbbVie or its Affiliates or Sublicensees as of the effective date of termination and continue to Conduct such Clinical Studies, at Galapagos’ cost, for up to […***…] ([…***…]) months to enable such transfer to be completed without interruption of any such Clinical Study; provided, that (a) Galapagos shall not have any obligation to continue any Clinical Study unless required by Applicable Law, and (b) with respect to each Clinical Study for which such transfer is expressly prohibited by the applicable Regulatory Authority, if any, AbbVie shall continue to Conduct such Clinical Study to completion, at Galapagos’ cost; and (v) assign (or cause its Affiliates or Sublicensees to assign) to Galapagos all agreements with any Third Party with respect to the Conduct of Clinical Studies specific to such terminated country(ies), including agreements with contract research organizations, clinical sites, and investigators, unless, with respect to any such agreement, (a) Galapagos declines such assignment, or (b) such agreement (1) expressly prohibits such assignment, in which case AbbVie shall cooperate with Galapagos in reasonable respects to secure the consent of the applicable Third Party to such assignment, or (2) covers products covered by Patents Controlled by AbbVie or any of its Affiliates in addition to the Products, in which case AbbVie shall, at Galapagos’ sole cost and expense, cooperate with Galapagos in all reasonable respects to facilitate the execution of a new agreement between Galapagos and the applicable Third Party.
Termination Agreement 8.01 Notwithstanding any other provision of this Agreement, WESTERN, at its sole option, may terminate either a Purchase Order or this Agreement at any time by giving fourteen (14) days written notice to CONSULTANT, whether or not a Purchase Order has been issued to CONSULTANT. 8.02 In the event of termination of either a Purchase Order or this Agreement, the payment of monies due CONSULTANT for work performed prior to the effective date of such termination shall be paid within thirty (30) days after receipt of an invoice as provided in this Agreement. Upon payment for such work, CONSULTANT agrees to promptly provide to WESTERN all documents, reports, purchased supplies and the like which are in the possession or control of CONSULTANT and pertain to WESTERN.
Letter Agreement The Company shall have entered into the Letter Agreement on terms satisfactory to the Company.
Cooperation Agreement If a Cooperating Institution is appointed, the Fund shall enter into a Cooperation Agreement with the Cooperating Institution setting forth the terms and conditions of its appointment.
Reimbursement Agreement The Sponsor entered into an Expense Reimbursement Agreement (“Reimbursement Agreement”) substantially in the form annexed as an exhibit to the Registration Statement pursuant to which the Sponsor has committed to fund the Company up to $1,750,000 for the Company’s expenses relating to investigating and selecting a target business and other working capital requirements prior to an initial Business Combination.
One Agreement This Agreement and any related security or other agreements required by this Agreement, collectively: (a) represent the sum of the understandings and agreements between the Bank and the Borrower concerning this credit; (b) replace any prior oral or written agreements between the Bank and the Borrower concerning this credit; and (c) are intended by the Bank and the Borrower as the final, complete and exclusive statement of the terms agreed to by them. In the event of any conflict between this Agreement and any other agreements required by this Agreement, this Agreement will prevail.
Construction of this Amendment; Participation Agreement (a) This Amendment shall be interpreted to be consistent with, and to facilitate compliance with and reliance on, Rule 30e-3 under the 1940 Act and Rule 498A (including paragraph (j) thereof) under the 1933 Act and any interpretations of those Rules by the Securities and Exchange Commission, its staff, courts, or other appropriate legal authorities. (b) To the extent the terms of this Amendment conflict with the terms of the Participation Agreement, the terms of this Amendment shall control; otherwise, and except as otherwise specifically set forth in this Amendment, the terms of the Participation Agreement shall continue to apply, and shall apply to the duties, responsibilities, rights and obligations of the Parties under and pursuant to this Amendment.
Agreement Amendment If either party hereto requests to amend this agreement, it shall notify the other party in writing, and the other party shall respond within one week. All amendments of this agreement must be made in writing by both parties, and such amendments shall be deemed as inseverable parts of this agreement.
Waiver and Agreement Neither the failure nor any delay on the part of Lender to exercise any right, power or privilege herein or under any of the other Loan Documents shall operate as a waiver thereof, nor shall any single or partial exercise of such right, power or privilege preclude any other or further exercise thereof or the exercise of any other right, power or privilege. No waiver of any provision in this Loan Agreement or in any of the other Loan Documents and no departure by Borrower therefrom shall be effective unless the same shall be in writing and signed by Lender, and then shall be effective only in the specific instance and for the purpose for which given and to the extent specified in such writing. No modification or amendment to this Loan Agreement or to any of the other Loan Documents shall be valid or effective unless the same is signed by the party against whom it is sought to be enforced.
Rental Agreement All of the Roommates agree to be bound by all of the terms of the Rental Agreement.

Accommodation Agreement Sample Clauses

Filter & Search

Related Clauses

Parent Clauses

Related to Accommodation Agreement